Salipro_logo_2lines.png
サリプロ・バイオテック (Salipro Biotech)、住友ファーマと研究提携を締結し、創薬プログラムを推進
September 12, 2023 02:00 ET | Salipro Biotech AB
本提携では、サリプロ・バイオテックの独自の専門知識とSalipro®プラットフォーム技術を活用して困難な薬物標的を安定化し、住友ファーマの創薬プログラムによる化合物の薬理学的特性を研究 する。 スウェーデン・ストックホルム発, Sept. 12, 2023 (GLOBE NEWSWIRE) -- スウェーデンのバイオテクノロジー企業であるサリプロ・バイオテックAB (Salipro...
22157.jpg
Over 1000 Orphan Drugs in Clinical Trials in the US - Eylea, Actimmune, Ravicti Among Key Approved Therapies
August 07, 2023 06:43 ET | Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
LOGO.jpg
QSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam®
April 26, 2023 08:00 ET | QSAM Biosciences Inc.
Austin, TX, April 26, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Vantage Market Research.png
Global Compound Management Market Size To Reach $897.1 Billion at a CAGR of 16.5% | Vantage Market Research
February 28, 2023 10:24 ET | Vantage Market Research
WASHINGTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Global Compound Management Market is valued at USD 355.5 Billion in 2021 and is projected to reach a value of USD 897.1 Billion by 2028 at a CAGR...
22157.jpg
Outlook on the Monkeypox Treatment Global Market to 2035 - Focus on Therapeutics, Vaccines and Diagnostic Kits
January 31, 2023 10:38 ET | Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Monkeypox Treatment Market: Focus on Therapeutics, Vaccines and Diagnostic Kits: Distribution by Type of Product, Drug Developers, Drug Candidates,...
22157.jpg
Opportunities in the Artificial Intelligence in Drug Discovery Market Investor Report: Savings of $8.57 Billion Enabled by AI
January 04, 2023 06:48 ET | Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global SARM1 Inhibitors Market Report 2022 to 2040 - by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies
December 16, 2022 07:23 ET | Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "SARM1 Inhibitors Market by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies: Industry Trends and Global...
22157.jpg
Immune Checkpoint Inhibitors Clinical Trial Analysis 2022: Wide Variety of Clinical and Preclinical Research Currently Ongoing Bodes Well for Growth
December 15, 2022 05:18 ET | Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical...
Global Artificial Intelligence (AI) in Drug Discovery Market
Artificial Intelligence In Drug Discovery Global Market Report 2022: Featuring Key Players IBM, Microsoft, Cloud Pharmaceuticals & Others
August 15, 2022 04:38 ET | Research and Markets
Dublin, Aug. 15, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022, By Technology, By Drug Type, By Therapeutic Type, By End-Users" report has...
Global Compound Management Market
Global Compound Management Market (2022 to 2030) - Rising Demand for Outsourcing Compound Management Services is Driving Growth
July 18, 2022 05:48 ET | Research and Markets
Dublin, July 18, 2022 (GLOBE NEWSWIRE) -- The "Global Compound Management Market Size, Share & Trends Analysis Report by Type (Products, Service), by Sample Type (Chemical Compounds, Bio...